Federation Des Caisses Desjardins Du Quebec Ab Cellera Biologics Inc. Transaction History
Federation Des Caisses Desjardins Du Quebec
- $21.3 Billion
- Q2 2025
A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 17,300 shares of ABCL stock, worth $106,741. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,300
Previous 15,300
13.07%
Holding current value
$106,741
Previous $34,000
73.53%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding ABCL
# of Institutions
148Shares Held
114MCall Options Held
488KPut Options Held
476K-
Baker Bros. Advisors LP New York, NY27.5MShares$170 Million0.96% of portfolio
-
Capital World Investors Los Angeles, CA13.4MShares$82.4 Million0.01% of portfolio
-
Baillie Gifford & CO10.4MShares$63.9 Million0.03% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL8.47MShares$52.3 Million0.01% of portfolio
-
Credit Suisse Ag Zurich, V84.55MShares$28.1 Million0.02% of portfolio
About AbCellera Biologics Inc.
- Ticker ABCL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 285,139,008
- Market Cap $1.76B
- Description
- AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...